To enhance sustainable return to work of cancer survivors of working age.
ID
Source
Brief title
Condition
- Miscellaneous and site unspecified neoplasms benign
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Sustainable return to work measured as return to work (yes/no) which is
sustained for at least four consecutive weeks. Return to work is regardless of
partial return to work (working a part of contract hours) or full return to
work (working all contract hours).
Secondary outcome
Full return to work (working all contract hours) for at least four consecutive
weeks.
Time in days to return to work (yes/no) for at least four consecutive weeks.
Return to work is regardless of partial return to work (working a part of
contract hours) or full return to work (working all contract hours).
Time in days to full return to work (working all contract hours) for at least
four consecutive weeks.
Work ability
Work limitations
Quality of life
Quality of work life
Return to work without extensive need for recovery
Cost-effectiveness of the web-based intervention Cancer@Work
Feasibility of the web-based intervention Cancer@Work
Intermediate effect of the intervention on self-management and work-related
self-efficacy.
Background summary
In the last decades, the survival rates of cancer have improved significantly
for most cancer types. For that reason, a growing number of cancer survivors of
working age is now able to remain in or return to work. However, a considerable
number of cancer patients still experience difficulties getting back to work or
becoming unemployed. It is important to diminish these adverse work outcomes
for cancer patients, as work is a key aspect of cancer survivorship and as work
is associated with higher levels of quality of life in cancer patients. To
reduce these negative consequences for cancer patients as well as for the
society at large, we developed an intervention to support return to work in
cancer patients. The hypothesis is that the patients who receive the web-based
intervention will have better work outcomes at 12 months of follow-up compared
to patients who receive care as usual.
Study objective
To enhance sustainable return to work of cancer survivors of working age.
Study design
Multi-centre non-blinded randomised controlled trial.
Intervention
The intervention consists of access to the web-based intervention, Cancer@Work,
which will be blended with care by their specialised nurse or social worker.
Cancer@Work, is a interactive, personal website, aimed at enhancing the return
to work of cancer survivors by means of tailor-made information, assignments
and movies. Patients will be supported in their use of Cancer@Work by their
specialised nurse or social worker of their treating hopsital.
Study burden and risks
There are no risks associated with participation. The web-based intervention is
developed, build and will be hosted by the ICT department of the AMC.
Since the use of the web-based intervention is not prescribed in terms of
length, frequency, and duration, the burden to participate is variable.
Patients themselves decide when to use the web-based intervention and which
content. The web-based intervention will be available for 12 months. The burden
to participate for all patients will be 4.30 hours for filling in 5
questionnaires spread during the 12 months of follow-up.
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
Primary diagnosis of cancer
Treated with curative intent at the hospital of recruitment
Between 18-62 years old
In paid employment or self-employed at cancer diagnosis
Exclusion criteria
Have a severe co-morbidity
Have no Internet access
Are not able to speak, read, and write Dutch sufficiently well
Receiving primary treatment in another hospital than hospital of recruitment.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
| Register | ID |
|---|---|
| CCMO | NL51798.018.14 |
| OMON | NL-OMON24044 |